Document is current
Any future updates will be listed below
-
Authors
Ham, Baknoon
Kim, Su Yeon
Kim, Young-Ae
Han, DoYeon
Park, Taehyun
Cha, Sumin
Jung, SungWook
Kim, Jong Hyeok
Park, Gisung
Gong, Gyungyub
Lee, Hee Jin https://orcid.org/0000-0002-4963-6603
Shin, Junyoung
-
Funding
Funding for this research was provided by:
Asan Institute for Life Sciences, Asan Medical Center (2018IL0169)
- License Information
-
More Information
Article History
Received: 17 August 2023
Revised: 25 April 2024
Accepted: 29 April 2024
First Online: 15 May 2024
Competing interests
: HJL is the CEO and owns stocks in NeogenTC Corp.
: This study was approved by the institutional review board of Asan Medical Center (approval no. 2016-0935), and written informed consent was obtained from the patients.
